Oncoinvent ASA

OB:ONCOI Stock Report

Market Cap: NOK 130.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oncoinvent Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OB:ONCOI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 25BuyNOK 14,399Anne AlvikIndividual8,500NOK 1.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONCOI?
Owner TypeNumber of SharesOwnership Percentage
Public Companies957,6920.98%
VC/PE Firms9,299,3619.51%
Individual Insiders9,979,05310.2%
Institutions19,778,83120.2%
Private Companies22,107,09722.6%
General Public35,621,30936.4%

Dilution of Shares: ONCOI only recently listed within the past 12 months

Top Shareholders

Top 23 shareholders own 63.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Skandinaviska Enskilda Banken AB (publ)
10,417,151NOK 13.9m0%0.01%
9.51%
Hadean Ventures
9,299,361NOK 12.4m0%no data
9.35%
John Fredriksen
9,143,749NOK 12.2m0%no data
5.03%
Sciencons AS
4,917,223NOK 6.5m0%no data
4.03%
Canica AS
3,936,216NOK 5.2m0%0.02%
3.11%
MP Pensjon PK
3,036,706NOK 4.0m0%0.06%
3.08%
Myrlid AS
3,011,440NOK 4.0m0%no data
2.81%
Sbakkejord AS
2,750,000NOK 3.7m0%no data
2.69%
Om Holding AS
2,634,000NOK 3.5m0%no data
2.44%
BNY Asset Management
2,388,758NOK 3.2m0%no data
2.2%
Helene Sundt AS
2,148,564NOK 2.9m0%no data
2.04%
Stavanger Forvaltning AS
1,995,593NOK 2.7m0%no data
1.19%
Lucellum AS
1,160,000NOK 1.5m0%no data
1.03%
Hillevågen Holding As
1,007,692NOK 1.3m0%no data
0.98%
Norda ASA
957,692NOK 1.3m0%no data
0.87%
Annexstad Hartvig Wennberg AS
845,865NOK 1.1m0%no data
0.86%
Finnvik Eiendom As
836,720NOK 1.1m0%no data
0.82%
Alpine Capital AS
800,000NOK 1.1m0%no data
0.36%
Charles O'Bryan-Tear
350,000NOK 465.5k0%no data
0.25%
Ingrid Akay
247,104NOK 328.6k0%no data
0.15%
Oystein Soug
150,000NOK 199.5k0%no data
0.077%
Kari Gronas
75,000NOK 99.7k0%no data
0.013%
Anne Alvik
13,200NOK 17.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/31 21:48
End of Day Share Price 2025/10/29 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Oncoinvent ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geir HolomDNB Carnegie